These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1213 related items for PubMed ID: 28852310

  • 1. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus.
    Sreedharan L, Mayne GC, Watson DI, Bright T, Lord RV, Ansar A, Wang T, Kist J, Astill DS, Hussey DJ.
    World J Gastroenterol; 2017 Aug 14; 23(30):5508-5518. PubMed ID: 28852310
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-143 and -205 expression in neosquamous esophageal epithelium following Argon plasma ablation of Barrett's esophagus.
    Dijckmeester WA, Wijnhoven BP, Watson DI, Leong MP, Michael MZ, Mayne GC, Bright T, Astill D, Hussey DJ.
    J Gastrointest Surg; 2009 May 14; 13(5):846-53. PubMed ID: 19190970
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. MicroRNA 223 is upregulated in the multistep progression of Barrett's esophagus and modulates sensitivity to chemotherapy by targeting PARP1.
    Streppel MM, Pai S, Campbell NR, Hu C, Yabuuchi S, Canto MI, Wang JS, Montgomery EA, Maitra A.
    Clin Cancer Res; 2013 Aug 01; 19(15):4067-78. PubMed ID: 23757351
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native Epithelium.
    Drahos J, Schwameis K, Orzolek LD, Hao H, Birner P, Taylor PR, Pfeiffer RM, Schoppmann SF, Cook MB.
    Cancer Epidemiol Biomarkers Prev; 2016 Mar 01; 25(3):429-37. PubMed ID: 26604271
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. miR-24-3p regulates CDX2 during intestinalization of cardiac-type epithelium in a human model of Barrett's esophagus.
    Gil-Gómez G, Fassan M, Nonell L, Garrido M, Climent M, Anglada R, Iglesias M, Guzzardo V, Borga C, Grande L, de Bolós C, Pera M.
    Dis Esophagus; 2021 Jul 12; 34(7):. PubMed ID: 33558874
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma.
    Slaby O, Srovnal J, Radova L, Gregar J, Juracek J, Luzna P, Svoboda M, Hajduch M, Ehrmann J.
    Carcinogenesis; 2015 May 12; 36(5):521-7. PubMed ID: 25784377
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma.
    Brabender J, Marjoram P, Lord RV, Metzger R, Salonga D, Vallböhmer D, Schäfer H, Danenberg KD, Danenberg PV, Selaru FM, Baldus SE, Hölscher AH, Meltzer SJ, Schneider PM.
    Cancer Epidemiol Biomarkers Prev; 2005 Sep 12; 14(9):2113-7. PubMed ID: 16172218
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Transforming human papillomavirus infection and the esophageal transformation zone: prime time for total excision/ablative therapy?
    Rajendra S, Sharma P.
    Dis Esophagus; 2019 Jul 01; 32(7):. PubMed ID: 31304554
    [Abstract] [Full Text] [Related]

  • 17. Stepwise radical endoscopic resection of the complete Barrett's esophagus with early neoplasia successfully eradicates pre-existing genetic abnormalities.
    Peters FP, Krishnadath KK, Rygiel AM, Curvers WL, Rosmolen WD, Fockens P, Ten Kate FJ, van Baal JW, Bergman JJ.
    Am J Gastroenterol; 2007 Sep 01; 102(9):1853-61. PubMed ID: 17509033
    [Abstract] [Full Text] [Related]

  • 18. [Radio frequency ablation of Barrett's esophagus--can the risk of esophageal adenocarcinoma be reduced?].
    Salminen P, Räsänen J, Ristimäki A, Saarnio J, Heikkinen M, Laine S, Koivisto T, Färkkilä M.
    Duodecim; 2014 Sep 01; 130(6):557-64. PubMed ID: 24724454
    [Abstract] [Full Text] [Related]

  • 19. Cyclooxygenase-2 expression in esophageal epithelium before and after photodynamic therapy for Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma.
    Yachimski P, Mino-Kenudson M, Sherwood ME, Puricelli WP, Nishioka NS, Lauwers GY.
    Virchows Arch; 2011 Dec 01; 459(6):581-6. PubMed ID: 22081106
    [Abstract] [Full Text] [Related]

  • 20. Circulating microRNA expression profiling revealed miR-92a-3p as a novel biomarker of Barrett's carcinogenesis.
    Fassan M, Realdon S, Cascione L, Hahne JC, Munari G, Guzzardo V, Arcidiacono D, Lampis A, Brignola S, Dal Santo L, Agostini M, Bracon C, Maddalo G, Scarpa M, Farinati F, Zaninotto G, Valeri N, Rugge M.
    Pathol Res Pract; 2020 May 01; 216(5):152907. PubMed ID: 32131978
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.